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Background: ESCRT proteins catalyze 
membrane budding and fission away from the 
cytosol  
Results: The ESCRT-III protein CHMP2B, 
polymerizes into tubular helical structures 
deforming the plasma membrane. 
Conclusion: CHMP2B, not only mediates 
recruitment of the ESCRT-dissociating ATPase 
VPS4, as previously proposed, but also moulds 
membranes. 
Significance: ESCRT-III polymerize into a 
novel kind of membrane deforming filaments 
distinct of actin and tubulin.   
 
Summary: The Endosomal Sorting 
Complexes Required for Transport (ESCRT-
0-III) allow membrane budding and fission 
away from the cytosol. This machinery is used 
during multivesicular endosome biogenesis, 
cytokinesis and budding of some enveloped 
viruses. Membrane fission is catalyzed by 
ESCRT-III complexes made of polymers of 
Charged Multivesicular Body Proteins 
(CHMPs) and by the AAA-type ATPase 
VPS4. How and which of the ESCRT-III 
subunits sustain membrane fission from the 
cytoplasmic surface remain uncertain. In 
vitro, CHMP2 and CHMP3 recombinant 
proteins polymerize into tubular helical 
structures, which were hypothesized to drive 
vesicle fission. However, this model awaits the 
demonstration that such structures exist and 
can deform membranes in cellulo. Here we 
show that depletion of VPS4 induces specific 
accumulation of endogenous CHMP2B at the 
plasma membrane. Unlike other CHMPs, 
overexpressed full-length CHMP2B 
polymerizes into long, rigid tubes that 
protrude out of the cell. CHMP4s relocalize at 
the base of the tubes, the formation of which 
depends on VPS4. Cryo-EM of the CHMP2B 
membrane tubes demonstrates that CHMP2B 
polymerizes into a tightly packed helical 
lattice, in close association with the inner 
leaflet of the membrane tube. This association 
is tight enough to deform the lipid bilayer in 
cases where the tubular CHMP2B helix varies 
in diameter or is closed by domes. Thus, our 
observation that CHMP2B polymerization 
scaffolds membranes in vivo, represents a first 
step towards demonstrating its structural role 




















Author manuscript, published in "Journal of Biological Chemistry 2011;286(46):40276-86"




Studies in yeast have revealed that protein 
complexes called ESCRTs (Endosome Sorting 
Complexes Required for Transport) play a 
pivotal role in intraluminal vesicle budding 
inside endosomes, an essential step for the 
sorting of receptors towards degradation (1-3). 
The particularity of ESCRT complexes is to 
induce membrane vesiculation with a topology 
that is inverted compared to coated vesicles 
budding from a donor membrane and released 
into the cytosol. Four ESCRT complexes have 
been characterized so far: ESCRT-0, -I, -II, -III. 
ESCRTs 0, I and II are recruited to membranes 
as complexes (4). In contrast, ESCRT-III 
assembles sequentially and transiently at 
membranes, and requires VPS4 for disassembly 
(5). Yeast ESCRT-III is composed of 7 highly 
related proteins. Each of them has one to three 
homologs in mammals, which are grouped into 8 
families designated CHMP1-7 (charged 
multivesicular body proteins) and IST1 
(increased sodium tolerance-1). In yeast, four 
ESCRT-III proteins essential for vesicle release 
have been shown to be recruited on endosomal 
membranes in the following order: two Vps20p 
subunits (CHMP6) recruited by ESCRT-II to 
nucleate the assembly of two Snf7p (CHMP4A-
C) spirals, which are capped by Vps24p 
(CHMP3) and Vps2p (CHMP2A,B) (6-8). The 
latter recruits VPS4 (9) (10), to catalyze 
disassembly of ESCRT-III (11-14). In vitro, 
yeast ESCRT-I and II are sufficient to form 
vesicles on GUVs and ESCRT-III induces 
membrane fission (15).  
In mammalian cells, ESCRT complexes also 
play a role at the plasma membrane during 
cytokinesis (16-19)  and budding of some 
enveloped viruses (20) (21-25). Although all 
ESCRT-III members and VPS4 are required 
during cell divison (17), siRNA knockdown 
experiments indicate that only one of the two 
CHMP2- and one of the three CHMP4-isoforms 
and their direct interaction are absolutely 
required for virus egress (26).  
Little direct evidence exists so far revealing 
how mammalian ESCRT-III complexes mould 
membranes in vivo.  ESCRT-III proteins are 
small helical assemblies, auto-inhibited in the 
cytosol and becoming activated upon interaction 
with a membrane (12,27-31). One common 
theme between CHMP proteins is their capacity 
to polymerize in vitro. CHMP1A polymerizes 
into large tubes, IST1 assembles into curled 
sheets (29) while CHMP4B associates into 
arrays of loose circular filaments (32). In 
contrast, CHMP3 and CHMP2A polymerize into 
helical tubular structures (12,29) that can be 
closed at one end to form dome-like structures. It 
has been hypothesized that the tight interaction 
of the dome with the membrane at the neck of 
the budding vesicle might lead to the closing of 
the neck and spontaneous membrane fission (33). 
In contrast to these structures observed in vitro, 
CHMP4B overexpression in cultured cells led to 
its assembly into circular filaments at the plasma 
membrane. Membrane tubes of unknown 
composition were emanating from the plasma 
membrane when CHMP4B was overexpressed 
together with catalytically inactive VPS4 (34). 
Recent evidence from HIV-1 budding suggests 
that although CHMP4 isoforms assemble within 
the neck, they do not suffice to induce membrane 
fission in the absence of CHMP2A or B. This 
suggests that CHMP2 may be the minimal 
fission machinery (26) requiring VPS4 to 
catalyze fission and virion release (35), 
consistent with the sequential recruitment of 
ESCRTs and VPS4 to the HIV-1 budding site 
(36). 
Here we report that downregulating VPS4 
leads to accumulation of endogenous CHMP2B 
at the plasma membrane, indicating its presence 
in ESCRT-III complexes formed transiently at 
the plasma membrane. When overexpressed, 
CHMP2B is recruited to the plasma membrane, 
where it forms long protrusions, partly 
depending on its capacity to bind VPS4. The 
capacity of CHMP2B to make plasma membrane 
protrusions is not shared by other CHMPs, and 
neither CHMP2A, CHMP3 nor CHMP4 
isoforms colocalize with CHMP2B inside tubes. 
However, CHMP4A and B tend to relocalize at 
the base of CHMP2B tubes. Cryo-electron 
microscopy of membrane tubes shed into the cell 
culture supernatant, demonstrates that CHMP2B 
polymerizes into a tightly packed helical 
polymer intimately associated with the inner 
leaflet of the bilayer.  Our results show for the 
first time that CHMP proteins can form tightly 
packed helical structures in vivo that associate 
with cellular membranes. Secondly, such 
structures vary in diameter to induce membrane 
constriction, which indirectly supports the dome 
model for membrane fission (33). Finally, our 
data demonstrate that in mammalian cells, 
CHMP2B is not only an adaptor protein for the 
recruitment of VPS4 as demonstrated in yeast, 





















membrane scaffolding.   
 
Experimental procedures 
DNA construct: The wild-type human CHMPs 
(2A, 3, 4A, 4B, 4C) cDNAs were cloned from 
HeLa cells by RT-PCR, in frame with a C-
terminal Flag inserted inside reverse primers 
(Table1). CHMP2B, CHMP2BIntron5-Flag, and 
CHMP2B-Flag, CHMP2BL207DL210D-Flag and 
CHMP2BL4DF5D-Flag were generated by PCR 
using plasmids containing HA-CHMP2B or 
GFP-VPS4B as templates, introducing Stop 
codon or point mutations inside primers where 
needed (all PCR primers used in this study are 
described Table S1). PCR fragments were 
inserted inside pcDNA3.1 vector using TOPO 
directional cloning kit (Invitrogen).  
For expression in bacteria, cDNA fragments 
derived from human full-length CHMP2B (wt 
CHMP2B and mutant L4DF5D), were subcloned 
in frame with a C-terminal 6x Histidine tag into 
the expression vector pETM-13, using NcoI and 
XhoI. Proteins were produced in E. coli strain 
BL21 codon plus (Invitrogen). 
GPF-AMSH was a generous gift from Sylvie 
Urbé. pCaggs GFP-VPS4B and pCaggs GFP-
VPS4 E235Q were described previously (37). 
Reagents and antibodies: Polyclonal antibodies 
against the C-terminal part of CHMP2B were 
purchased from Abcam (ab33174). Polyclonal 
anti-CHMP4A (H-52) and CHMP4B (C-12) 
were obtained from Santa Cruz. Polyclonal anti-
CHMP4B (ab105767) was from Abcam. 
Polyclonal antibodies against VPS4A and B 
were a kind gift from W.I. Sundquist (University 
of Utah). Monoclonal and polyclonal anti-FLAG 
antibodies were obtained from Sigma-Aldrich. 
Rabbit polyclonal antibody against β-Tubulin 
was a generous gift from A. Andrieux (Inserm 
U836, Grenoble). Secondary antibodies 
conjugated to Alexa Fluor 488, Alexa Fluor 594, 
Alexa 594-WGA and Texas Red-X -phalloidin 
were obtained from Molecular Probe. 
Cell cultures, transfections: For 
immunofluorescence, HeLa cells were seeded 
onto sterile glass coverslips in 6-well plates (105 
cells per well) in Dulbecco’s Modified Eagle’s 
Medium (DMEM) (Gibco) containing 10% fetal 
bovine serum (FBS) (Sigma), and 2 mM L-
glutamine (Sigma). Cells were transfected 24 h 
later with 1 µg DNA, and 6 µl jetPEI 
transfection reagent (Polyplus), mixed in a final 
volume of 200 µl of 150 mM NaCl. For 
cotransfection, 1 µg of CHMP2B containing 
plasmid was mixed with 500 ng of the plasmids 
encoding the other proteins. Cells were fixed and 
processed for immunostaining 24 or 36 h after 
transfection. 
For actin destabilisation, cells were incubated 
1 h with 1 µM Cytochalasin D or with 0.2 mg/ml 
Latrunculin A (Sigma).  
SiRNA transfection: HeLa cells transfected with 
a mixture containing 10 nM of each of the 
previously described siRNA duplexes (38) 
(VPS4A: CCGAGAAGCUGAAGGAUUAtt; 
VPS4B: CCAAAGAAGCACUGAAAGAtt) 
using Lipofectamine RNAi MAX (Invitrogen). 
Cells were transfected again after 24 h and fixed 
24 h later. Control cells were transfected with 20 
nM of siRNA duplexes against LucGL2 
(CGUACGCGGAAUACUUCGAtt). 
The extent of down-regulation was estimated by 
western blot analysis of cell lysates. 
Western immunoblotting: Cells were lysed in 
RIPA buffer containing protease inhibitors 
(Complete, Roche Molecular). Proteins (20 µg 
total protein per lane) were separated on SDS-
polyacrylamide gels (10%) and analyzed by 
immunoblotting with the indicated antibodies.  
Immunofluorescence: Cells were fixed and 
immunostained as described in (39). In brief, 
cells were fixed with 4% paraformaldehyde. 
After 3 washes in PBS, cells were permeabilized 
with PBS containing 0.5% Triton X-100 in 
blocking solution (PBS containing 5% goat pre-
immune serum) for 30 min. Primary antibodies 
diluted in blocking solution were then incubated 
for 1h. After washing in PBS, cells were 
incubated for 1h with secondary antibodies 
conjugated to Alexa Fluor 488, Alexa Fluor 594, 
Alexa 594-WGA or Alexa488-phalloidin. After 
3 washes in PBS coverslips were rinsed in water 
and mounted in Mowiol.  
For staining of F-actin Texas Red-X Phalloidin 
was incubated together with the secondary 
antibodies. For delineating cellular membranes, 
live cells were washed in HBSS, incubated 10 
min at 4°C with Alexa 494-WGA (5 µg/mL in 
HBSS) and washed in PBS before fixation. 
Liposome Flotation Assay: Lipsomes were 
made of synthetic 1-Stearoyl-2-Oleoyl-sn-
Glycero-3-Phosphocholine (SOPC) and 1,2-
Dioleoyl-sn-Glycero-3-Phosphoserine (DOPS) 
from Avanti Polar Lipids. Lipids were 
homogeneously mixed in chloroform to achieve 
a 8/2 molar ratio. Dried thin lipid films were 
obtained by evaporation. Lipids were hydrated in 
20 mM HEPES pH 7  to a final concentration of 
2.5 mg/mL. The translucent solution was then 





















polycarbonate membrane (Avanti Polar Lipids). 
The average diameter of the liposomes was 
estimated to range between 200 to 400 nm by 
dynamic light scattering measurement and 
electron microscopy  
Proteins and large unilamellar vesicles (LUVs) 
were incubated overnight. The solution was 
mixed with an equal volume of 80% (w/v) 
sucrose in 20 mM HEPES pH 7 resulting in a 
final sucrose concentration of 40% (w/v) with a 
final LUV concentration of 0.625 mg/mL.  300 
μL of this solution was overlayed with 100 μL of 
30, 20 and 10% (w/v) sucrose in no-salt buffer. 
The gradient was then subjected to 
ultracentrifugation at 190 000 g for 6 h at 4°C. 
After ultracentrifugation, gradients were 
separated into seven fractions. Sucrose 
concentration of each fraction was determined by 
refractometry; one third of each fraction was 
analyzed by SDS-PAGE.  
Confocal microscopy Images of fluorescent 
cells were acquired with a Zeiss LSM-710 laser 
scanning confocal microscope with a 63x Plan-
Apochromat objective (NA 1.4). Laser power 
was adjusted to maximize the dynamic range of 
each sample. For dual-color samples, the 
adjustable spectral window of fluorescence 
collection was set for each channel with a singly 
colored control sample, so that cross-
contamination between channels was avoided.  
Since CHMP2B tubes protrude out of the cell in 
a large Z range, stacks of optical sections were 
acquired with the required electronic 
magnification. Image files were processed with 
ImageJ. Except when mentioned, images 
represent maximum intensity projections.  
CHMP2B tube purification: For isolation of 
CHMP2B tubes, HeLa cells were seeded in 10 
cm culture dishes (approximately 106 cells/well). 
The culture medium was the same as mentioned 
above, except that FBS was previously cleared 
by 60 000 g centrifugation to remove potential 
contaminants. Cells were transfected 24 h later 
with 3 µg DNA, and 18 µl jetPEI transfection 
reagent (Polyplus-transfection), mixed in a final 
volume of 600 µl of 150 mM NaCl. Culture 
media harvested 36 h after transfection were 
centrifuged twice at 300 g for 5 min to remove 
debris and then at 30 000 g (1 h) to pellet 
membranes. The resulting pellet (P1) was 
washed once with HBS (150 mM NaCl, 20 mM 
Hepes, pH 7.4), resuspended and incubated for 
30 min at 4°C in HBS containing 1 mM 
AMPPnP (SIGMA), complete™ protease 
inhibitor (Roche Applied Science), and 1% 
Triton X100. Half of this suspension was 
centrifuged at 20 000 g for 30 min, the pellet 
(P2) was re-suspended in the same volume as S2.  
Identical volumes of P1, S2, P2 were analyzed 
by western blot together with the cell lysate (20 
µg proteins estimated using BCA  protein assay 
reagent (Pierce).  
Electron microscopy: 
Immuno-EM analysis of CHMP2b expressing 
cells: Cells were fixed with 2% 
paraformaldehyde and 0.2% glutaraldehyde in 
phosphate buffer 0.1M, pH 7.3 during 2 h. Cells 
were then gently detached using a cell scraper, 
centrifuged at 1200 rpm during 5 minutes and 
embedded in 10% gelatine. The cell pellet was 
then cut into 1 mm3 pieces. These samples were 
cryoprotected during 4 h in 2.3 M sucrose and 
frozen in liquid nitrogen. Ultrathin cryosections 
of 40 nm were made at -120°C using an ultra-
cryo-microtome (Leica-Reichert) and retrieved 
with a 1:1 solution of 2.3 M sucrose and 2% 
methylcellulose according to the Tokuyasu 
protocol (40). Cryosections were first incubated 
with primary polyclonal anti-Flag antibody 
(Sigma), and revealed with protein A-gold 
conjugate (CMC, Utrecht). Double immunogold 
labeling was performed sequentially using 15 nm 
protein A gold to recognize anti-CHMP4A and 
10 nm protein A gold to detect CHMP2B. 
Labeled cryosections were viewed at 80 kV with 
a 1200EX JEOL TEM microscope and images 
were acquired with a digital camera (Veleta, SIS, 
Olympus).  
Negative staining: P1 pellet obtained from the 
culture media of ten 100 mm dishes of HeLa 
cells transfected with CHMP2B-Flag were 
resuspended in 80µl HBS. 6 µl of this sample 
was incubated during 10 minutes on an EM grid 
coated with Formvar and carbon. Grids were 
then quickly blotted and washed 3 times in water 
before staining with 1% uranyl acetate during 1 
min, followed by blotting to remove excess 
liquid. For immunolabeling, samples were 
permeabilized with Triton X100 1% during 20 
minutes and labeling was performed after 
extensive washing with water using an anti 
CHMP2B antibody against the whole protein. 
Protein A gold (CMC, Utrecht) was used to 
reveal the antibody. Finally, grids were stained 
with 1% uranyl acetate pH 4 during 1 minute. 
Grids were viewed under a transmission electron 
microscope (JEOL 1200EX) and images 






















Cryo-EM: P1 pellets obtained from the culture 
medium of thirty 100 mm dishes were 
resuspended in 40 µl HBS. 4 ml of sample were 
loaded onto a Quantifoil R2/1 holey grid 
(Quantifoil Micro Tools GmbH, Germany), 
blotted for 1 to 2 s to remove the excess liquid 
and then rapidly plunged into liquid ethane 
cooled using liquid nitrogen. The frozen grid was 
transferred into a FEI Tecnai Polara electron 
microscope. Images were taken under low dose 
conditions at 300 kV (less than 10 e-/Å2) and 
with a nominal magnification of 45 000 and a 
defocus between 2 and 3 µm using a CCD 
camera (GATAN ultrascan 4000). 
2D average: Two-dimensional averaging of 
particles was performed by selecting a total of 35 
boxes (900 x 900 pixels) equally spaced along 
one tube using the x3d program (41)  and 
averaging them together after cross-correlation 
using SPIDER (42) 
 
Results 
CHMP2B localizes to the plasma 
membrane upon VPS4 knock-down. 
Immunostaining of CHMP4A, B and 2B 
revealed that all endogenous proteins were 
homogeneously distributed throughout the 
cytoplasm. SiRNA knock-downs of VPS4A and 
VPS4B (Fig. S2A) led to a relocalization of 
cytosolic CHMP4A and CHMP4B to 
intracellular patches, possibly reflecting their 
accumulation at the surface of endosomes (Fig. 1 
A,B). In contrast, similar depletion of VPS4 led 
to relocalization of endogenous CHMP2B from 
the cytoplasm into patches, which were 
associated with the plasma membrane in some 
cells (Fig. 1C, D and S2B). This suggests that 
VPS4 is required to dissociate plasma membrane 
based ESCRT-III complexes containing 
CHMP2B and thus intimately controls ESCRT-
III activity at the plasma membrane. 
Expression of wild type CHMP2B induces 
cell surface protrusions. 
Overexpressed CHMP2B was 
homogeneously distributed throughout the 
cytoplasm. However, in 10 % of cells, the 
cytoplasmic staining was partially or entirely lost 
and CHMP2B was relocated to the plasma 
membranes, producing long protrusions pointing 
out into the culture medium (Fig. 2A). Some 
protrusions had a length of up to several tens of 
microns. Fusion of a Flag peptide to the C-
terminal part of CHMP2B increased the capacity 
of the protein to assemble into surface 
protrusions, which were detected in about 40% 
of CHMP2B-Flag positive cells (Fig. 2A, B). 
Projection in the x-z plane (Fig. 2A) and 3D 
reconstruction (S1 and S2 videos) of cells 
expressing CHMP2B or CHMP2B-Flag, show 
that the tubes protrude on the sides and above the 
cell and are rarely attached to the cell culture 
substrate. In some cases however, CHMP2B 
protrusions detached from the cell surface were 
observed lying on the cell culture substrate.  
Immunoelectron microscopy of CHMP2B-
Flag expressing cells demonstrated the presence 
of tubular, electron dense structures covered by a 
single membrane (Fig. 2E, F). The hollow 
electron dense structures were labeled with Flag 
antibodies revealing the presence of CHMP2B 
along the entire length of the tubes (Fig. 2F). In 
tube cross sections Flag immunolabeling was 
seen in the lumen of the tubes indicating that the 
C-terminal part of CHMP2B points towards the 
interior of the tubular structure (Fig.2E).  
Expression of CHMP2B also induced the 
formation of tubes in HEK 293T cells (not 
shown). CHMP2B expressed in post-mitotic 
neurons also deformed the membrane into 
protrusions in which it accumulates (Fig. S3A). 
This demonstrates that CHMP2B protrusions do 
not result from cell retraction occurring during 
cell migration or division.   
The N-terminal end of CHMP2B is 
required to deform the plasma membrane. 
In contrast to CHMP2B-Flag and wild-type 
CHMP2B, N-terminally-Flag-tagged CHMP2B 
(Flag-CHMP2B) remained cytoplasmic and 
failed to induce growth of surface protrusions 
(Fig. 2B, C). Similarly, an HA-tag fused to the 
N-terminus blocked the capacity of CHMP2B to 
induce membrane tubulation (not shown). 
Western blot analysis showed similar levels of 
expression of CHMP2B, Flag-CHMP2B or 
CHMP2B-Flag (Fig. S3B) demonstrating that the 
inability of N-terminally tagged versions of 
CHMP2B to induce tubule formation is not due 
to differences in their expression level. 
Based on these observations, we reasoned 
that the N-terminal part of the protein might be 
crucial for deforming membranes. The CHMP2B 
N-terminal 8 amino-acids are conserved 
throughout the CHMP family. In particular Leu4 
and Phe5 of CHMP2B, followed by a cluster of 
positively charged residues (Lys and Arg) are 
conserved within all CHMPs (Fig. S1B). 
Expression of the double mutant L4D/F5D 
(CHMP2BL4DF5D-Flag) did not deform the 
plasma membrane into protrusions (Fig. 2B, C). 





















membrane binding, a liposome flotation assay 
was employed using purified recombinant 
CHMP2B and CHMP2BL4DF5D. The presence of 
CHMP2B in the upper fractions demonstrated 
the capacity of the protein to interact with 
liposomes (Fig. 2D). In contrast, most 
CHMP2BL4DF5D stayed in the bottom fraction 
demonstrating that the L4D/F5D mutation 
impairs CHMP2B lipid bilayer interaction in 
vitro. These data confirm the requirement of an 
intact N-terminus for CHMP2B function. 
Co-expression of CHMP4 with CHMP2B 
affects CHMP2B’s capacity to induce 
membrane tubulation.  
 Because formation of CHMP2B cell 
protrusions depends on an intact N-terminus, we 
re-examined the expression of C-terminally Flag-
tagged CHMP2A, CHMP3 and the CHMP4A, B 
and C isoforms. None of them induced 
membrane protrusions when expressed alone. 
Although CHMP2A and CHMP3 polymerize 
into tubes in vitro, no such structures could be 
observed in vivo upon co-expression of 
CHMP2A-Flag and CHMP3-Flag (not shown).   
CHMP4 co-expressed with CHMP2B abolished 
CHMP2B protrusions and led to relocalization of 
CHMP2B to CHMP4-containing structures (Fig. 
3A). In contrast, neither CHMP2A nor CHMP3 
abolished formation of CHMP2B protrusions 
(not shown). These observations thus suggest 
that CHMP4 isoforms regulate CHMP2B’s 
capacity to polymerize and deform the plasma 
membrane.  
Immunostaining with antibodies against 
CHMP4A and CHMP4B of CHMP2B-
overexpressing cells revealed that the 
endogenous proteins were both recruited at the 
base of CHMP2B protrusions (Fig. 3B, C and 
video S3). This localization was confirmed using 
double immunogold labeling of CHMP2B-Flag 
expressing cells with anti-Flag and anti 
CHMP4A antibodies: CHMP4A was confined to 
a dense core material at the base of the tube 
whereas CHMP2B was distributed along the 
entire length (Fig. 3D).  
CHMP2B membrane tube formation is 
regulated by VPS4.  
The C-terminal MIT domain-interacting motif 
(MIM) of CHMP2B recruits the ATPase VPS4 
(9). Accordingly, we found that GFP-VPS4B 
decorated the entire length of CHMP2B-
containing protrusions (Fig. 4A). In contrast, the 
ubiquitin hydrolase GFP-AMSH, which binds to 
the MIMs of CHMP1A, B, 2A and 3, but not that 
of CHMP2B, (28,43), was absent from 
CHMP2B protrusions (Fig. 4A). This further 
indicates that none of these proteins take part in 
the making of CHMP2B protrusions.  
We next tested whether VPS4 binding to 
CHMP2B is necessary for its membrane 
tubulating activity. Here we used a CHMP2B 
double mutation L207D/L210D 
(CHMP2BL207DL210D-Flag) which impairs VPS4B 
recruitment (9) (Fig. S1). CHMP2BL207DL210D-
Flag did not co-localize with GFP-VPS4B 
confirming its inability to bind the ATPase (Fig. 
4B). Unexpectedly, CHMP2BL207DL210D-Flag was 
concentrated inside patches but almost never 
induced tube formation This observation 
suggests that VPS4 is required for the formation 
or integrity of CHMP2B tubes. However, a 
CHMP2B mutant (CHMP2Bintron5), which lacks 
part of the C-terminus including the MIM 
domain, formed patches at the plasma membrane 
like CHMP2BL207DL210D-Flag but nevertheless 
polymerized efficiently into membrane tubes 
(Fig. 4B). GFP-VPS4B was not detected inside 
tubes made of CHMP2Bintron5-Flag. We conclude 
that interaction of VPS4 to the C-terminal MIM 
domain is required for full-length CHMP2B to 
form membrane tubes. This was further 
supported by the fact that co-expressing 
catalytically inactive VPS4B (VPS4E235Q) with 
CHMP2B, strikingly increased the number of 
cells making tubes compared to cells expressing 
CHMP2B only (Fig. 4C). The requirement for 
the VPS4-CHMP2B interaction can be overcome 
by deletion of the C-terminal part which is 
thought to release autoinhibition as in the case of 
CHMP2Bintron5. Thus, VPS4 interaction might be 
necessary to release the autoinhibition in full-
length CHMP2B, a process that is required to 
induce CHMP membrane association and 
polymerization. However, it is not necessary to 
form or maintain the structures of the 
protrusions.  
Relationship between CHMP2B and actors 
of membrane deformation 
Classically, actin and tubulin underlie plasma 
membrane protrusions. No immunostaining of β-
tubulin was detected inside CHMP2B tubes (Fig. 
5A). Absence of microtubules inside CHMP2B 
protrusions was also obvious from the electron-
microscopy data (Fig. 2E). Thus CHMP2B-
induced protusions are not related to microvilli 
or other protrusions made by microtubules.  
F-actin stained by Phalloidin was almost 
never present inside CHMP2B protrusions 
demonstrating that it is not necessary to keep 





















role of actin for maintaining CHMP2B 
protrusions was confirmed by the fact that 
latrunculin A (Fig. 5C) or cytochalasin D (not 
shown), which dramatically disrupted the actin 
cytoskeleton, did not affect their integrity. Our 
observations thus demonstrate that CHMP2B 
assembly can scaffold plasma membrane tubes 
independently of actin and tubulin. 
Membrane tubes made of CHMP2B are 
resistant to detergent.  
Because CHMP2B protrusions are often 
found shed from HeLa cells, we collected them 
from the culture medium of CHMP2B 
expressing cells. After low speed centrifugation, 
media were centrifuged at 30 000g. The pelleted 
material (P1) was solubilized in 1% Triton X-
100 and centrifuged at 20 000 g (P2 and S2). 
Western blot analysis demonstrated the presence 
of large amounts of CHMP2B in the P1 pellets, 
the vast majority remaining insoluble in Triton-
X100 (Fig. 6A). This is in good agreement with 
the known resistance of ESCRT-III complexes to 
non-ionic detergents. No CHMP2B immuno-
positive material was recovered from P1 or P2 
pellets prepared from cell supernatants of cells 
transfected with CHMP2BL4DF5D-Flag in 
accordance with the inability of the mutant to 
make tubes. 
EM examination of P1 pellets negatively 
stained with uranyl acetate demonstrated the 
presence of numerous rigid tubes surrounded by 
plasma membrane (not shown). Their diameter 
ranged from 70 to 350 nm. No such tubes could 
be seen in similar supernatants of untransfected 
cells. Immunogold labeling performed after 
permeabilization, revealed the presence of 
CHMP2B along the entire length of the tubes 
(Fig. 6B).  
Cryo-EM observation reveals CHMP2B 
polymerized into a tightly packed helical 
structure.  
We next observed CHMP2B tubes present in 
P1 pellets using cryo-EM to better characterize 
their structure (Fig. 6C-F and S4). In these 
conditions, the diameter of the tubes ranged from 
100 to 400 nm. Regular striations perpendicular 
to the longitudinal axis of the tube could be 
revealed. The hollow nature of the tubes was 
demonstrated as they were sometimes filled with 
small vesicles (Fig. 6D). Regardless of the 
diameter of the tubes, the striations of CHMP2B 
tubes were regular (Fig. 6D-F and S4) and 
spaced by a 32 Å gap as determined by Fourier 
transform of an image, indicating a helical 
structure with a pitch of 32 Å (Fig. S4). The 
CHMP2B protein lattice was tightly linked to the 
internal leaflet of the membrane derived from the 
plasma membrane. In some cases the tube was 
constricted for example from a diameter of  ~ 80 
nm to ~ 16 nm. Because the lateral striation 
remains well visible, constriction is most likely 
induced by gradually reducing the number of 
CHMP protomers per helical turn (Fig. 6E). 
Sometimes tubes had a succession of two 
uniform segments with different diameters (not 
shown) or presented closed ends with continuous 
membrane (Fig 6F, S4). These analyses show 
that CHMP2B assembles into a helical polymer 




ESCRT-III catalyzes membrane budding and 
fission processes during MVB biogenesis, 
cytokinesis and enveloped virus budding 
(25,44,45). In yeast sequential assembly of 
VPS20p (CHMP6), Snf7p (CHMP4), Vps24p 
(CHMP3) and Vps2p (CHMP2) is required for 
function whereas SNF7p was suggested to 
constitute the driving force of membrane fission 
(6-8). The importance of Snf7 was further 
highlighted by giant unilamellar vesicles (GUV) 
budding assays showing that vesicles can be 
released into the lumen of the GUV by yeast 
ESCRT-III Vps20p (CHMP6), Snf7p (CHMP4) 
and Vps24p (CHMP3) (15). However, the 
mammalian system might differ in that CHMP4 
still plays a crucial role but requires in addition 
CHMP2 to catalyze membrane fission: although 
CHMP4 isoforms are recruited to the interior of 
the membrane neck of budding HIV-1 virions, 
virions are not released in the absence of both 
CHMP2 isoforms (17). Furthermore, VPS4 is 
recruited last and before virion release (35,36). 
Similarly CHMP4 in conjunction with CHMP2A 
have been implicated in constriction and 
membrane fission at the cytokinetic midbody 
(17,19,46). Thus both CHMP4 and CHMP2 play 
important roles in HIV-1 release and cytokinesis. 
Here we show that overexpression of intact 
CHMP2B is sufficient to induce the formation of 
membrane tubes protruding from the cell surface. 
The capacity of CHMP2B to make cell 
protrusions and to bind to membranes in vitro 
depends on an intact N-terminal end suggesting 
that this domain participates in the regulation of 
the interaction between the lattice and the inner 
membrane leaflet. Even though membrane 
recruitment of, and deformation by CHMP2B 





















this property has escaped detection in previous 
studies. This can be explained by the fact that all 
the other studies used tagging of the protein at 
the N-terminus, which clearly abolishes its 
capacity to form plasma membrane tubes. 
Even if CHMP proteins vary extensively in 
their primary sequence, they share a common 
folded structure with an N-terminal basic domain 
interacting with the C-terminal acidic regulatory 
domain. Because CHMPs are cytosolic, they 
require an activation step to polymerize on 
membranes (12,27-29). The autoinhibition is 
thought to be lifted by displacement of the C-
terminal region from the N-terminal core, which 
subsequently permits polymerization at 
membranes. The fact that wild type CHMP2B is 
able to form tubes indicates that the protein 
needs to be activated prior to polymerization at 
the plasma membrane. The AAA-ATPase VPS4 
could be part of this activation through binding 
to the C-terminal MIM domain of CHMP2B, 
thus releasing auto-inhibition. A similar 
mechanism has already been described for 
activation of CHMP3 by AMSH (28). Indeed 
mutations in the VPS4 binding site of CHMP2B 
prevent membrane tube formation. Furthermore, 
co-expression with catalytically inactive VPS4B 
increases the propensity of CHMP2B to 
polymerize into tubes. In humans, dominant 
mutations in CHMP2B cause frontotemporal 
dementia (FTD) (47-49). One mutation generates 
a distinct aberrant transcript, CHMP2Bintron5, 
which encodes a protein lacking the α6 helix thus 
rendering the protein constitutively active. 
CHMP2Bintron5 mutant induces tube formation 
demonstrating that the lack of VPS4 binding can 
be overcome by the absence of the C-terminal 
regulatory domain.  
On the other hand, the ATPase activity of 
VPS4 is known to regulate the dissociation of 
ESCRT-III complexes (11,13,14). Accordingly, 
downregulation of VPS4A and B revealed the 
accumulation of cytoplasmic CHMP4A-
containing ESCRT-III complexes. In contrast, 
the same downregulation led to preferential 
accumulation of endogenous CHMP2B in 
plasma membrane patches. This suggests that 
ESCRT-III complexes forming transiently at the 
plasma membrane are major sites of CHMP2B 
polymerization. Altogether our results suggest 
that VPS4 plays a dual regulatory role: binding 
to CHMP2B would structurally favor 
polymerization into tubes, whereas its ATPase 
activity depolymerizes plasma membrane 
ESCRT-III complexes. CHMP2Bintron5 
polymerization would escape control by VPS4 
potentially contributing to its pathogenic activity 
(39). 
A remarkable finding was the recruitment of 
endogenous CHMP2B in VPS4 knocked-down 
cells at the plasma membrane, which correlates 
well with the fact that the overexpressed protein 
makes tubes only at the cell surface. This 
preferential recruitment of CHMP2B at the 
plasma membrane could explain our recent 
observation in neurons of its involvement in the 
shaping of dendritic spines, which are small 
protrusions corresponding to post synaptic parts 
of synapses (39). It is also in good agreement 
with the crucial role played by CHMP2s in HIV-
1 virus egress (26).  
None of the CHMPs tested so far, including 
the closest homolog CHMP2A, polymerized into 
tubes or copolymerized with CHMP2B on the 
plasma membrane, although they all tended to 
concentrate at their base. However, using co-
transfection experiments, only CHMP4 isoforms 
had a drastic effect in blocking CHMP2B 
tubulating activity. The dominant negative effect 
of CHMP4 on CHMP2B tube formation may be 
explained by sequestering of CHMP2B by the 
overexpressed CHMP4. On the other hand, the 
presence of CHMP4 at the base of the tubes 
suggests that it also plays a positive role in that it 
sets the stage for CHMP2B membrane 
polymerization. Similarly, CHMP2 isoforms 
have no effect on HIV-1 budding in the absence 
of CHMP4 isoforms consistent with the absence 
of CHMP2 in the membrane necks of budding 
virions in the absence of CHMP4 (26).  
Recruitment of Flag-CHMP4B at the plasma 
membrane has already been observed using 
“deep etched” electron microscopy. In this case 
the protein polymerizised into filaments, which 
self-associated into circular arrays underneath 
the plasma membrane (34). Expression of C-
terminal deleted CHMP4A or B or co-expression 
of the full length protein together with an 
ATPase dead version of VPS4 (VPS4BE235Q) led 
to the appearance of buds and tubes pointing out 
of the cells. The identity of the CHMPs making 
these hollow tubes was not defined, but our 
results open the possibility that they represent 
CHMP2B polymers.  
Cryo-EM analyses of isolated membrane 
tubes demonstrated the presence of a protein 
lattice in close association with the inner leaflet 
of the tube membrane. Immunogold labeling 
indicates that the protein lattice is made of 





















staining of CHMP2B along the entire length of 
cellular membrane tubes. The CHMP2B protein 
lattice present in the tubes displays a lateral 
striation that is produced by helical symmetry; 
thus tube formation most likely followed the 
biophysical principle of membrane buckling as 
proposed for ESCRT-III polymer assembly (50). 
The pitch of the helix was determined by cryo 
EM to be 32 Å. Furthermore, immunogold 
labeling revealed that the arrangement of 
CHMP2B within the helix must be such that the 
C-terminal part points inside the lumen. These 
characteristics have already been observed in the 
case of CHMP2A/CHMP3 tubular structures 
assembled in vitro in the absence of membranes 
(12) indicating common structural principles for 
CHMP polymerization. The CHMP2B tubes 
varied in diameter and the CHMP2B lattice was 
able to constrict the membrane tube down to a 
diameter of 16 nm; furthermore, tube ends are 
closed and often reveal dome-like structures 
covered with continuous membrane. The induced 
membrane constriction and the observation of 
tubes with dome-like structural ends tightly 
covered by membrane, indirectly support the 
following membrane fission model: the building 
up of a dome-like CHMP protein lattice attracts 
and bends membranes sufficiently to induce neck 
thinning leading to spontaneous membrane 
fission (33). Furthermore our observations are in 
agreement with the tomography data that present 
spiral CHMP2A tubes at the cytokinetic 
midbody with a diameter of 17 nm (46). Thus 
both CHMP2A and CHMP2B can constrict 
membranes to narrow diameters. Because none 
of the other CHMPs have yet been shown to 
induce membrane constriction it is tempting to 
speculate that CHMP2 polymers catalyze the 
final membrane fission step, as suggested for 
HIV-1 budding (26), by providing sufficient 
membrane bending energy that leads to close 
apposition of the membranes within the 
membrane neck of a virus or vesicle or within 
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Figure Legends 
Figure 1: VPS4A and B downregulation induces plasma membrane accumulation of endogenous 
CHMP2B. HeLa cells were depleted of VPS4A and VPS4B using a mixture of SiRNA against both 
proteins (right panels). Control cells were transfected with an irrelevant SiRNA (left panels). Confocal 
section of control cells or of cells depleted of VPS4, immunostained with antibodies against CHMP4A 
(A), CHMP4B (B), or CHMP2B (C). Enlargements of the boxed regions are shown on the right. (D) 
Confocal sections of VPS4 depleted cells treated with Alexa 594-WGA to delineate membranes. Cells 
were immunostained using anti-CHMP4A (left panel) or anti-CHMP2B (right panel). Bars: 20 µm. 
 
Figure 2: Overexpression of CHMP2B or CHMP2B-Flag induces formation of long cell surface 
protrusions in which they concentrate. HeLa cells were transfected with the indicated plasmids and 
immunostained 36 h later. Except otherwise stated, photographs presented in all figures are maximal 
intensity projections of confocal image stacks. In A and C bottom panels represent projections in the 
x-z plane. Bars: 20 µm. (A) CHMP2B immunostaining of cells transfected with the empty vector 
reveals a homogeneous cytoplasmic localization of the protein.  Overexpression of CHMP2B and 
CHMP2B-Flag induces the formation of cell surface protrusions, in which CHMP2B concentrates. 
Note the absence of cytoplasmic staining in tube forming cells. (B) Percentage of transfected cells 
displaying tubes as revealed with anti-CHMP2B antibodies. For each condition, 200 CHMP2B-
expressing cells were counted. Data from 3 independent experiments are plotted. Standard error bars 
are shown. (C) Flag-CHMP2B and CHMP2BL4DF5D-Flag do not induce surface protrusions. (D) 
Flotation experiments demonstrate that mutations in L4-F5 impair the capacity of CHMP2B to 
associate with membranes in vitro. Purified recombinant full-length CHMP2B and CHMP2BL4DF5D 
were mixed with liposomes. Liposomes were floated on a sucrose gradient, fractions run on SDS-
PAGE and proteins revealed by Coomassie staining. (E, F) Flag Immunogold labeling of cells 
overexpressing CHMP2B-Flag. Cross sections of tubes reveal the presence of the C-terminal Flag 
lining the lumen of a hollow, electron-dense structure closely associated with the membrane of tubes; 
longitudinal sections reveal the presence of CHMP2B along the entire length of the tubes. Bars: 200 
nm.  
 
Figure 3: Relationship between CHMP4s and CHMP2B induced protrusions. HeLa cells were 
transfected with the indicated plasmids and immunostained 36 h later. (A) CHMP4A-Flag or 
CHMP4B-Flag, co-expressed with similar amounts of CHMP2B, block the capacity of CHMP2B to 
form protrusions. Note the relocalization of CHMP2B inside CHMP4A or CHMP4B patches. In cells 
expressing CHMP2B-Flag only, immunostaining with anti-CHMP4A (B) or anti-CHMP4B (C) 
antibodies reveals the relocalization of endogenous CHMP4A and CHMP4B at the base of CHMP2B 
tubes. The right panels show enlargement of the boxed regions in the merged panels. In all cases, Bars: 
20 µm. (D) Double immunogold labeling of a tube emanating from a cell overexpressing CHMP2B-
Flag: anti-FLAG staining (10 nm beads, black arrow heads) reveals the presence of CHMP2B along 
the entire length of the tube; anti CHMP4A (15 nm beads, white arrows) reveals CHMP4A labeling 
restricted at the base of the tube. Bars: 200 nm. 
 
Figure 4: Relationship between VPS4 and CHMP2B protrusions. HeLa cells were co-transfected 
with the indicated plasmids and observed 36 h later. (A) In cells transfected with the control plasmid 





















both GFP-VPS4B and CHMP2B, VPS4 is mainly present inside CHMP2B tubes. In contrast, AMSH 
is not recruited inside CHMP2B protrusions made by cells expressing both GFP-AMSH and 
CHMP2B.  (B) CHMP2BL207D-L210D-Flag, mutated in the MIM domain, accumulates in plasma 
membrane patches but does not induce protrusions. CHMP2Bintron5, which lacks the C-terminal α6 
helix containing the MIM domain, forms everting tubes. GFP-VPS4 is recruited neither inside 
CHMP2BL207DL210D-Flag patches nor inside CHMP2Bintron5-Flag containing tubes. (C). The catalytically 
inactive form of VPS4B (GFP-VPS4BE235Q) increases the proportion of cells displaying CHMP2B 
protrusions: HeLa cells were transfected with CHMP2B together with GFP-VPS4BE235Q and observed 
24 h later. For each condition, 200 cells, from three independent experiments were counted. Standard 
error bars are shown. Mann-Whitney statistical analysis was used (p<0.0011). Bars: 20 µm. 
 
Figure 5: HeLa cells CHMP2B protrusions do not contain actin or tubulin. Immunostaining with 
anti-β-Tubulin antibody (A) and staining with TexasRed-Phalloidin (B) of HeLa cells overexpressing 
CHMP2B demonstrate the absence of tubulin and F-actin inside CHMP2B tubes. (C) Latrunculin A 
treatment (0.1 µg/mL; 60 min) induces depolymerization of actin but does not collapse CHMP2B 
tubes.  
 
Figure 6: Characterization of tubes pelleted from culture media of CHMP2B expressing cells. 
(A) Western blotting analysis using anti-CHMP2B  of culture media of CHMP2B, CHMP2B-Flag and 
CHMP2BL4DF5D-Flag expressing cells. L: cell lysates; P1: 30 000 g pellet of culture media. P2, S2: P1 
pellets solubilized in 1% Triton X-100 were centrifuged at 20 000 g: most of the CHMP2B-containing 
material present in culture media is resistant to detergent extraction. No CHMP2B pelletable material 
could be recovered from media of CHMP2BL4DF5D-Flag expressing cells.  
(B) P1 pellets of culture medium of CHMP2B-Flag expressing cells contain tubes made up of 
CHMP2B. P1 pellets were fixed, permeabilized and immunolabeled with anti-CHMP2B antibodies 
revealed by protein A gold (10 nm).  
(C,D,E,F) Cryo EM analysis of P1 pellets prepared from culture medium from CHMP2B-Flag 
expressing cells reveals the structure of CHMP2B tubes: (C) Low magnification shows tubes with a 
length reaching at least 8 µm. (D) Striations perpendicular to the longitudinal axis can be seen across 
the width of the tube. Asterisk indicates a 50 nm vesicle inside the tube. (E) Constriction of a tube 
with no change in the helix pitch. (F) Dome closing one end of a tube. The inner leaflet of the 
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